Sh3,000.00
Brustan (325/400 mg) Tablet is a combination medicine used to relieve pain associated with:
| Settings | BRUSTAN TABLETS 10's remove | 220 BETA\NEO EAR\EYE remove | Atenolol 50 Anol remove | Brufen Tablets remove | Diclopar gel remove | Acefen Tablets remove |
|---|---|---|---|---|---|---|
| Image |  |  |  |  |  |  |
| SKU | ||||||
| Rating | ||||||
| Price | Sh3,000.00 | Sh1,500.00 | Sh4,000.00 | Sh4,000.00 | Sh3,500.00 | Sh6,000.00 |
| Stock | ||||||
| Availability | ||||||
| Add to cart | ||||||
| Description |
| |||||
| Content | Brustan (325/400 mg) Tablet is a combination medicine used to relieve pain associated with:
| combination medications for use in both the ears and eyes may be prescribed for certain conditions, such as:
| Anol 50mg Tablet belongs to a group of medicines called beta-blockers. It is used to treat high blood pressure (hypertension), angina (heart-related chest pain), irregular heart rhythms (arrhythmia). It also helps to prevent future heart attacks and stroke and migraines. | Brufen is indicated in periarticular conditions such as frozen shoulder (capsulitis), bursitis, tendonitis, tenosynovitis and low back pain; Brufen can also be used in soft tissue injuries such as sprains and strains. Brufen is also indicated for its analgesic effect in the relief of mild to moderate pain such as dysmenorrhoea, dental and post-operative pain and for symptomatic relief of headache, including migraine headache. | Diclopar-Activa is used in the treatment of localised forms of soft-tissue rheumatism (e.g. tendovaginitis, shoulder-hand syndrome, bursitis and periarthropathy), localised rheumatic diseases (e.g. osteo-arthritis of the spine and peripheral joints) and post-traumatic inflammation of the tendons, ligaments, muscles and joints (e.g. due to sprains, strains or bruises). | Acefen Tablet is a combination of Ibuprofen and Paracetamol, a pain-relieving medicine. |
| Weight | ||||||
| Dimensions | N/A | N/A | N/A | N/A | N/A | N/A |
| Additional information |
Reviews
There are no reviews yet.